Study design for a randomised controlled trial to explore the modality and mechanism of Tai Chi in the pulmonary rehabilitation of chronic obstructive pulmonary disease

BMJ Open

Volumn 6, Issue 8, 2016, Pages

  Fu, Juan Juan ^a   Min, Jie ^a   Yu, Peng Ming ^a   McDonald, Vanessa M ^b,c   Mao, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BERG BALANCE SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DIZZINESS; DYSPNEA; EXERCISE; FAINTNESS; FALLING; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MIDDLE AGED; MUSCLE CRAMP; MYALGIA; OUTCOME ASSESSMENT; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; STUDY DESIGN; TAI CHI; THERAPY EFFECT; THORAX PAIN; TREATMENT DURATION; TREATMENT INDICATION; UNCONSCIOUSNESS; WALKING; CHINA; FEMALE; KINESIOTHERAPY; MALE; METHODOLOGY; PROCEDURES;

AGED; CHINA; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESEARCH DESIGN; SINGLE-BLIND METHOD; SURVEYS AND QUESTIONNAIRES; TAI JI;

EID: 84983086207     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011297     Document Type: Article

References (63)

1. Agustí A, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-60.
2. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;(2):CD003793.
3. Brooks D, Lacasse Y, Goldstein RS. Pulmonary rehabilitation programs in Canada: national survey. Can Respir J 1999;6:55-63.
4. Levack WM, Weatherall M, Reeve JC, et al. Uptake of pulmonary rehabilitation in New Zealand by people with chronic obstructive pulmonary disease in 2009. N Z Med J 2012;125:23-33.
5. Field T. Tai Chi research review. Complement Ther Clin Pract 2011;17:141-6.
6. Hempel S, Taylor SL, Solloway MR, et al. Evidence-based synthesis program reports. Evidence map of Tai Chi. Washington DC: Department of Veterans Affairs (US), 2014.
7. Yan JH, Guo YZ, Yao HM, et al. Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PLoS ONE 2013;8:e61806.
8. Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med 2004;164:493-501.
9. Chen YW, Hunt MA, Campbell KL, et al. The effect of Tai Chi on four chronic conditions: cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: a systematic review and meta-analyses. Br J Sports Med 2016;50:397-407.
10. Guo JB, Chen BL, Lu YM, et al. Tai Chi for improving cardiopulmonary function and quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clin Rehabil 2016;30:750-64.
11. Wu W, Liu X, Wang L, et al. Effects of Tai Chi on exercise capacity and health-related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2014;9:1253-63.
12. Li G, Yuan H, Zhang W. Effects of Tai Chi on health related quality of life in patients with chronic conditions: a systematic review of randomized controlled trials. Complement Ther Med 2014;22:743-55.
13. Chan AW, Lee A, Suen LK, et al. Effectiveness of a Tai chi Qigong program in promoting health-related quality of life and perceived social support in chronic obstructive pulmonary disease clients. Qual Life Res 2010;19:653-64.
14. Chan AW, Lee A, Suen LK, et al. Tai chi Qigong improves lung functions and activity tolerance in COPD clients: a single blind, randomized controlled trial. Complement Ther Med 2011;19:3-11.
15. Chan AW, Lee A, Lee DT, et al. Evaluation of the sustaining effects of Tai Chi Qigong in the sixth month in promoting psychosocial health in COPD patients: a single-blind, randomized controlled trial. Scientific World Journal 2013;2013:425082.
16. Du S, Ding L, Wang C, et al. The effects Taijiquan practice on exercise endurance and lung function of patients with chronic obstructive pulmonary disease. Chin J Rehabil Med 2013;28:374-6.
17. Du S, Ding L, Wang C, et al. The effects of Taijiquan practice on the BODE and SGRQ of COPD patients. Chin J Sports Med 2013;32:403-7.
18. Gu G, Zhou Y, Wang D, et al. Effects of shadow boxing training on exercise endurance and quality of life of patients with chronic obstructive pulmonary disease. Natl Med J China 2012;92:952-5.
19. Leung RW, McKeough ZJ, Peters MJ, et al. Short-form Sun-style Tai Chi as an exercise training modality in people with COPD: a randomised controlled trial. Eur Respir J 2013;41:1051-7.
20. Li Q, Fang W, Liu C. The effect of taijiquan combined with respiratory exercise training on rehabilitation of patients with stable chronic obstructive pulmonary disease. Chin J Rehabil Med 2012;27:825-8.
21. Niu R, He R, Luo BL, et al. The effect of tai chi on chronic obstructive pulmonary disease: a pilot randomised study of lung function, exercise capacity and diaphragm strength. Heart Lung Circ 2014;23:347-52.
22. Ng L, Chiang LK, Tang R, et al. Effectiveness of incorporating Tai Chi in a pulmonary rehabilitation program for Chronic Obstructive Pulmonary Disease (COPD) in primary care - A pilot randomized controlled trial. Eur J Integr Med 2014;6:248-58.
23. Wang Y, Mo J, Cheng D, et al. Effects of Tai Chi exercise on quality of life and BODE for COPD patients. Chin J Rehab Med 2014;8:745-7.
24. Yao Y. Effect of tai chi chuan on chronic obstructive pulmonary disease. Chin J Rehabil Theory Practice 2004;10:439-40.
25. Yeh GY, Roberts DH, Wayne PM, et al. Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study. Respir Care 2010;55:1475-82.
26. Morgan N, Irwin MR, Chung M, et al. The effects of mind-body therapies on the immune system: meta-analysis. PLoS ONE 2014;9:e100903.
27. Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun 2016;51:1-11.
28. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
29. Fu JJ, McDonald VM, Baines KJ, et al. Airway IL-1beta and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest 2015;148:618-29.
30. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Updated 2011. http://www.goldcopd.com
31. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
32. Sacket DL, Straus SE, Richardson WS. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone, 1997
33. Dettori JR. Loss to follow-up. Evid Based Spine Care J 2011;2:7-10.
34. Billinger SA, Loudon JK, Gajewski BJ. Validity of a total body recumbent stepper exercise test to assess cardiorespiratory fitness. J Strength Cond Res 2008;22:1556-62.
35. Lan C, Chen SY, Lai JS. The exercise intensity of Tai Chi Chuan. Med Sport Sci 2008;52:12-19.
36. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64.
37. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1081-93.
38. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
39. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
40. Morris AH, Kanner RE, Crapo RO. Clinical pulmonary function testing: a manual of uniform laboratory procedures. Salt Lake City, UT: Intermountain Thoracic Society, 1984.
41. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
42. Berg K, Norman KE. Functional assessment of balance and gait. Clin Geriatr Med 1996;12:705-23.
43. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001;49:664-72.
44. Crişan AF, Oancea C, Timar B, et al. Balance Impairment in Patients with COPD. PLoS ONE 2015;10:e0120573.
45. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
46. Fu JJ, Gibson PG, Simpson JL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration 2014;87:63-74.
47. Kim HY. Statistical notes for clinical researchers: post-hoc multiple comparisons. Restor Dent Endod 2015;40:172-6.
48. Herbert RD. How to estimate treatment effects from reports of clinical trials. I: Continuous outcomes. Aust J Physiother 2000;46:229-35.
49. Puri KS, Suresh KR, Gogtay NJ, et al. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med 2009;55:131-4.
50. O'Donnell DE, Webb KA. Mechanisms of dyspnea in COPD. In: Mahler DA, O'Donnell DE, eds. Dyspnea: mechanisms, measurement, and management, 2nd ed. Lung biology in health and disease series. Vol 208. Boca Raton, FL: Taylor & Francis Group, 2005:29-58.
51. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
52. American Thoracic Society. Dyspnea: mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999;159:321-40.
53. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007;4:145-68.
54. Tandon MK. Adjunct treatment with yoga in chronic severe airways obstruction. Thorax 1978;33:514-17.
55. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med 2006;119:166.e117-28.
56. Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 2012;7:e37483.
57. Fu JJ, McDonald VM, Gibson PG, et al. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res 2014;6:316-24.
58. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52.
59. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008;13:128-33.
60. Yeh SH, Chuang H, Lin LW, et al. Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells. Br J Sports Med 2006;40:239-43.
61. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
62. Looney MA, Rimmer JH. Aerobic exercise equipment preferences among older adults: a preliminary investigation. J Appl Meas 2003;4:43-58.
63. Ige OM, Olarewaju RK, Lasebikan VO, et al. Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2010;52:197-201.